Additional Information for DaVita Inc.

This is a multi-location business. Need to find a different location?

close

Find a Location

DaVita Inc. has 181 locations, listed below.

*This company may be headquartered in or have additional locations in another country. Please click on the country abbreviation in the search box below to change to a different country location.

BBB accredited

Near

Country

USUnited States

Please enter a valid location.

Filter

• 

  DaVita Inc.

  2000 16th St Denver, CO 80202-5117

• 

  DaVita Inc.

  7490 S Camino De Oeste Tucson, AZ 85746

• 

  DaVita Inc.

  203 E 2nd Ave Escondido, CA 92025

• 

  DaVita Inc.

  1445 30th St San Diego, CA 92154

• 

  DaVita Inc.

  2232 Verus St San Diego, CA 92154

Headquarters

2000 16th St, Denver, CO 80202-5117

BBB File Opened:

10/21/2010

Years in Business:

23

Business Started:

10/5/2000

Business Started Locally:

10/5/2000

Business Incorporated:

6/12/2009

Type of Entity:

Corporation

Alternate Business Name

• DaVita Kidney Care
• DaVita Dialysis

Business Management

• Javier Rodriguez, CEO
• Michael D Staffieri, COO
• Robert Lang, President
• Joel Ackerman, CFO

Contact Information

Principal

• Javier Rodriguez, CEO
• Michael D Staffieri, COO
• Robert Lang, President
• Joel Ackerman, CFO

Customer Contact

• Javier Rodriguez, CEO

Additional Contact Information

Phone Numbers

• (888) 484-7505
  Other Phone
• (800) 244-0680
  Other Phone

Additional Business Information

Government Actions

Government Action: BBB reports on known government actions involving business’ marketplace conduct:

Settlement Agreement between the United States of America; DaVita Inc; and Relator Dennis Kogod

 

The following describes a government action that has been resolved by either a settlement or a decision by a court or administrative agency. If the matter is being appealed, it will be noted below.

 

On July 18, 2024, a Settlement Agreement ("Agreement") was entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General of the Department of Health and Human Services, (collectively, the "United States"); DaVita Inc. ("DaVita"); and Relator Dennis Kogod.

 

The claims resolved by the settlement are allegations only. There has been no determination of liability.

 

DaVita Inc., headquartered in Denver, Colorado, has agreed to pay $34,487,390 to resolve allegations that it violated the False Claims Act by paying kickbacks to induce referrals to DaVita Rx, a former subsidiary that provided pharmacy services for dialysis patients, and by paying kickbacks to nephrologists and vascular access physicians to induce the referral of patients to DaVita’s dialysis centers.

 

The Anti-Kickback Statute prohibits anyone from offering or paying, directly or indirectly, any remuneration — which includes money or any other thing of value — to induce referrals of patients or of items or services covered by Medicare, Medicaid and other federally funded programs.

 

The United States alleges that DaVita paid kickbacks to a competitor to induce referrals to DaVita Rx to serve as a “central fill pharmacy,” or prescription fulfillment provider, for that competitor’s Medicare patients’ prescriptions. In exchange, DaVita paid to acquire certain European dialysis clinics and agreed to extend a prior commitment to purchase dialysis products from the competitor. DaVita would not have paid the price that it did for these deals without the competitor’s commitment to refer its Medicare patients’ prescriptions to DaVita Rx in return.

 

The United States further alleges that DaVita provided management services to vascular access centers owned by physicians in a position to refer patients to DaVita’s dialysis clinics. DaVita paid improper remuneration to these physician-owners in the form of uncollected management fees to induce referrals to DaVita’s dialysis centers.

 

Finally, the United States alleges that DaVita paid improper remuneration to a large nephrology practice to induce referrals to DaVita’s dialysis clinics. DaVita gave the practice a right of refusal to staff the medical director position at any new dialysis center that opened near the nephrology practice and paid the practice $50,000 despite the practice’s decision not to staff the medical director position for those clinics. 

 

The civil settlement includes the resolution of claims brought under the qui tam or whistleblower provisions of the False Claims Act by Dennis Kogod, a former Chief Operating Officer of DaVita Kidney Care. Under those provisions, a private party can file an action on behalf of the United States and receive a portion of any recovery. The qui tam case is captioned United States ex rel. Kogod v. DaVita, Inc., et al., No. 17-cv-02611-PAB (D. Colo.). Kogod will receive $6,370,000 of the proceeds from the settlement.

 

The resolution obtained in this matter was the result of a coordinated effort between the Civil Division’s Commercial Litigation Branch, Fraud Section, and the U.S. Attorney’s Office for the District of Colorado with assistance from HHS-OIG.

 

The investigation and resolution of this matter illustrates the government’s emphasis on combating health care fraud. One of the most powerful tools in this effort is the False Claims Act. Tips and complaints from all sources about potential fraud, waste, abuse and mismanagement can be reported to HHS at 800-HHS-TIPS (800-447-8477).

 

For more information, please contact the United States Department of Justice, Office of Public Affairs at 202-514-2007 or https://www.justice.gov/opa.

Click here for details

Business Categories

Dialysis Clinic